Drug intelligence / Profile preview

banxia baizhu tianma granules

Development stage
Unknown
Lead developer
Yiling Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Banxia Baizhu Tianma Granules (also known as Banxia Baizhu Tianma Tang Granules) is a classic traditional Chinese medicine (TCM) formula prepared as granules. Originating from the Qing Dynasty medical text 'Yi Xue Xin Wu' (Medical Insights) by Cheng Guopeng, the formula traditionally consists of eight herbal ingredients: Pinellia rhizome (Banxia), Gastrodia rhizome (Tianma), Atractylodes macrocephala rhizome (Baizhu), Poria (Fuling), Red tangerine peel (Juhong/Chenpi), Licorice root (Gancao), Fresh ginger (Shengjiang), and Jujube fruit (Dazao). It is indicated for the treatment of wind-phlegm rising syndrome, which manifests as vertigo, headache, chest stuffiness, nausea, and vomiting. The formula works by drying dampness, transforming phlegm, extinguishing internal wind, and strengthening the spleen. In China, it is approved as a Class 3.1 classic TCM formula, with commercialized versions developed and marketed by companies such as CR Sanjiu and Sichuan Guangda Pharmaceutical (a subsidiary of Livzon).

Brand names
999
Other names
Ban Xia Bai Zhu Tian Ma TangBan Xia Bai Zhu Tian Ma Tang GranulesBanhabaekchulcheonmatangBanxia Baizhu Tianma DecoctionBanxia Baizhu Tianma Decoction GranulesBanxia Baizhu Tianma KeliBanxia Baizhu Tianma TangBanxia Baizhu Tianma Tang GranulesHangebyakujutsutemmatoPinellia-Atractylodes Macrocephala-Gastrodia Decoction半夏白术天麻汤颗粒半夏白术天麻颗粒

Beyond the preview

Go deeper on banxia baizhu tianma granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on banxia baizhu tianma granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call